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Abstract
Community-acquired pneumonia (CAP) is an important clinical condition with regard to patient mortality, patient morbidity,
and healthcare resource utilization. The assessment of the likely clinical course of a CAP patient can signiﬁcantly inﬂuence decision
making about whether to treat the patient as an inpatient or as an outpatient. That decision can in turn inﬂuence resource utiliza-
tion, as well as patient well being. Predicting dire outcomes, such as mortality or severe clinical complications, is a particularly
important component in assessing the clinical course of patients. We used a training set of 1601 CAP patient cases to construct
11 statistical and machine-learning models that predict dire outcomes. We evaluated the resulting models on 686 additional
CAP-patient cases. The primary goal was not to compare these learning algorithms as a study end point; rather, it was to develop
the best model possible to predict dire outcomes. A special version of an artiﬁcial neural network (NN) model predicted dire out-
comes the best. Using the 686 test cases, we estimated the expected healthcare quality and cost impact of applying the NN model in
practice. The particular, quantitative results of this analysis are based on a number of assumptions that we make explicit; they will
require further study and validation. Nonetheless, the general implication of the analysis seems robust, namely, that even small
improvements in predictive performance for prevalent and costly diseases, such as CAP, are likely to result in signiﬁcant improve-
ments in the quality and eﬃciency of healthcare delivery. Therefore, seeking models with the highest possible level of predictive per-
formance is important. Consequently, seeking ever better machine-learning and statistical modeling methods is of great practical
signiﬁcance.
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1. Introduction
This paper describes a retrospective evaluation of ma-
chine-learning and statistical methods that predict the
chance of dire outcomes in patients who present with
community acquired pneumonia (CAP). We use the
term dire outcome to denote a severe complication, death
within 30 days of presentation, or an admission to the
intensive care unit (ICU) for either respiratory failure,
respiratory or cardiac arrest, or shock/hypotension.1
CAP is an important clinical condition, both from the
point of view of resource-utilization and patient out-
comes. Previous studies have estimated that each year
in the US there are about 4.1 million CAP patients of
whom approximately 1.2 million are hospitalized [1,2].
Taken together, pneumonia and inﬂuenza have been
ranked as the sixth leading cause of death in this country
[3]. In the US, CAP has been responsible for 64 million
days of restricted activity, 39 million days of bed con-
ﬁnement, and 10 million days of work lost annually
[4]. The aggregate cost of hospitalization of CAP pa-
tients is estimated to total almost $9 billion per year in
the US [5].
One use of predicting the probability of dire out-
comes of CAP patients would be to assist clinicians in
making the admission decisions for those patients. The
admission decision is one of the most cost-sensitive deci-
sions made in the care of CAP patients, with the average
cost of care for inpatients being 18–28 times greater than
the cost of care for outpatients [5]. Ideally, patients who
could be safely treated as outpatients (typically at home)
on oral antibiotics would be so treated, while usually the
remaining patients would be admitted to the hospital
and treated with intravenous antibiotics.
Researchers have previously developed models that
predict mortality as an outcome of patients with CAP.
The PSI model in particular was developed to predict
patient mortality within 30 days of presentation with
CAP [7], based on 20 demographic and clinical vari-
ables. The models described in the current paper predict
dire outcomes more broadly than mortality, to include
severe complications and admission to the ICU. It seems
likely that decisions about where to treat CAP patients
are based not just on mortality, but also on other possi-
ble dire outcomes. Thus, predicting dire outcomes more
broadly seems useful.
To learn computer models that predict dire outcomes
of CAP patients, we applied several induction methods
to a training set (i.e., derivation set) of CAP patient re-
cords. These models were then evaluated using a CAP
test set (i.e., validation set). The modeling methods we
used are logistic regression, rule-based learning, neural
networks, ﬁnite mixture model techniques, simple (i.e.,
naı¨ve) Bayes methods, and a combination of ﬁnite mix-
ture modeling and simple Bayes. All of these methods
have been previously described in the literature,
although some of them are likely to be unfamiliar to
many readers. Our primary goal was not to compare
these learning algorithms as a study end point; rather,
it was to develop the best possible model to predict dire
outcomes and then estimate the impact of its use on
healthcare quality and cost.
We describe the predictive performance of each mod-
el on the test set, where the area under the ROC curve is
used as a measure of performance. These results suggest
which of the tested models are likely to perform best in
predicting dire outcomes in future patients with CAP.
We also describe performance when the training set con-
tains more and more cases. These results indicate
whether we can expect further improvement in the mod-
els performance if the training set were expanded by
collecting additional cases of patients with CAP. Final-
ly, for the modelM with the best predictive performance
on the full training set, we estimate the impact that M
would have on healthcare quality and cost, if it were ap-
plied in helping guide decisions about whether to treat
CAP patients at home or in the hospital.
2. The CAP database
This section describes the CAP database used in this
project. The description borrows from previous litera-
ture that reports other analyses of that database [6,7].
The pneumonia PORT database on CAP patients was
collected using a prospective cohort study of hospital-
ized and ambulatory care patients. The study was con-
ducted from October 1991 to March 1994 at ﬁve
medical institutions in three geographic locations: the
University of Pittsburgh Medical Center (UPMC), a
942-bed university teaching hospital and St. Francis
Medical Center (SFMC), a 427-bed community teaching
hospital, in Pittsburgh, Pennsylvania; Massachusetts
General Hospital (MGH), an 899-bed university teach-
ing hospital, and Harvard Community Health Plan-
Kenmore Center (HCHP), a 44,931-member health-care
center within a staﬀ-model health maintenance organi-
zation (only ambulatory patients were enrolled from this
site), in Boston, Massachusetts; and Victoria General
Hospital (VGH), a 637-bed university teaching hospital,
in Halifax, Nova Scotia, Canada. Pittsburgh and Boston
were selected because prior work by the investigators
suggested that patient management strategies diﬀered
between these areas.
Eligible patients were identiﬁed by trained research
assistants through daily reviews of emergency, admit-
ting, and radiology department records and patient logs.
Clinical eligibility was determined by patient interview
1 A detailed description of the deﬁnition we use for a dire outcome is
given in Appendix B. Unless stated otherwise, the term dire outcome (in
italics) in this paper refers speciﬁcally to that deﬁnition.
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and review of medical records. Eligibility criteria were
that a patient must: (1) be at least 18 years of age, (2)
have one or more symptoms suggestive of pneumonia,
(3) have radiographic evidence of pneumonia within
24 h of presentation, and (4) provide informed consent
for base-line and follow-up interviews [7]. For radiologic
evidence of pneumonia, the report of the local clinical
radiologist was used. Patients with one or more of the
following criteria were not eligible for enrollment: (1)
hospitalized within 10 days prior to initial presentation
with CAP; (2) clinical diagnosis of AIDS or known po-
sitive antibody titre for HIV; (3) deﬁnitive diagnosis
other than pneumonia that was the likely explanation
for the pulmonary inﬁltrate (e.g., pulmonary edema or
pulmonary embolus); or (4) previous enrollment in the
cohort study.
During the study enrollment period, 4002 individuals
who satisﬁed all the criteria for study eligibility were
identiﬁed, of whom 2287 (57.1%) were enrolled. Based
on chart review, hundreds of data items were collected
for each of the 2287 patients. In the research reported
here, we used 158 clinical variables in the PORT data-
base that are often available just before the admission
decision, including demographic information, history
and physical examination information, laboratory re-
sults, and chest X-ray ﬁndings.2 Variables that are con-
tinuous typically have associated discretized variable
versions (e.g., age appears as a continuous variable
and as a discrete variable containing six age ranges),
leading to a total of 196 variables. Appendix A contains
a list of the 196 variables. Patients with records in the
database were followed prospectively to assess their vital
status and a variety of outcomes 30 days after the radio-
graphic diagnosis of pneumonia. A patient was consid-
ered to have experienced a dire outcome if any of the
following occurred to the patient: (1) death within 30
days of presentation, (2) an initial ICU admission for
respiratory failure, respiratory or cardiac arrest, or
shock, or (3) the presence of one or more severe compli-
cations. Appendix B contains additional details about
the criteria used to deﬁne dire outcomes.
3. Predictive models
This section describes the predictive models that were
applied in the experiments reported here, as well as how
the models were induced from the PORT CAP database.
Table 1 gives a short summary of all the models. While
there are many alternative machine-learning techniques
to the ones in Table 1, we believe these methods repre-
sent a diverse sample of capable machine-learning meth-
ods. The remainder of this section provides additional
details about the methods we used.
Throughout this section, the term feature denotes a
variable-value pair. Thus age is a variable, while
age = 80 is a feature. Also, f denotes an arbitrary vari-
able, while f 0 denotes an arbitrary variable-value pair.
3.1. The Simple Bayes (SB) model
This section describes the Simple (aka Naı¨ve) Bayes
model and how we constructed several such models.
3.1.1. Summary of the Simple Bayes model
The Simple Bayes classiﬁer (SB) [8–10] is based on the
well-known version of Bayes rule in which ﬁndings are
assumed to be conditionally independent given a patient
state.
Given a set of patient features F 0 ¼ ff 01; . . . ; f 0ng we
can compute the posterior probability of a patient state
S 0 as follows (under the assumption of independence of
the ﬁndings given the state of S):
P ðS0jF 0Þ ¼ PðS
0ÞQf 02F 0P ðf 0jS0ÞP
S P ðSÞ
Q
f 02F 0P ðf 0jSÞ
;
where an accented symbol indicates that a variable or set
of variables has a particular state to which they are
instantiated. The summation is taken over all possible
states of S. Fig. 1 graphically depicts the conditional
independence of the ﬁnding variables given the patient
state variable S.
Often, the conditional probability P (f 0|S 0) is estimated
as ðNf 0 ;S0 þ aÞ=ðNS0 þ bÞ, where Nf 0 ;S0 is the number of pa-
tient cases containing both ﬁnding f 0 (e.g., cough = yes)
and state S 0 (e.g., dire outcome = yes), NS0 is the number
of cases containing state S 0, and the parameters a and b
are positive real numbers that act to smooth the probabil-
ity estimate when NS0 is small. Similarly, the prior proba-
bility P (S 0) can be estimated as ðNS0 þ cÞ=ðN þ dÞ, where
N is the total number of patient cases, and c and d are po-
sitive real numbers. The values we used for a, b, c, and d
are described in the next section.
3.1.2. Induction of Simple Bayes models without variable
selection (SB.D and SB.C)
We constructed simple Bayes models that include all
the available variables. We built one model based only
on discrete variables (SB.D) and another based on con-
tinuous and discrete variables (SB.C). The SB.D model
contains a total of 158 predictors, obtained by removing
the 38 continuous variables. Among the 38 continuous
variables, all but three (AGEPRES, DYMDSYM, and
MENTSTAT) have associated discretized variables.3
2 Information that we used on vital signs and laboratory results
represent the ﬁrst values available to physicians after patient
presentation.
3 For our purpose, the COPD Severity variable (COPDSEV) was
treated as a discrete variable, since it has only seven values.
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The SB.C model contains a total of 161 predictors, ob-
tained by removing the discretized versions of 35 contin-
uous variables.
For parameter estimation for discrete variable f, we
used a equal to 1 and b equal to the number of states
of f. For estimating P (S), we used c equal to 1, and d
equal to 2, since the dire outcome variable has two states.
In SB.C, continuous variables were modeled using con-
ditional Gaussian distributions [11].
3.1.3. Induction of a Simple Bayes model using variable
selection (SB.VS.D)
The system was applied to the entire set of variables,
including continuous and discrete. Continuous variables
were not modeled on a numeric scale, but represented as
a single discrete state per value for each unique real
value.
We performed variable selection by dividing the
training data into two smaller sets called train–train
(70%) and train–test (30%). We used a wrapper ap-
proach [12] that searched over the train–train cases
for the subset of variables that give the best perfor-
mance on the train–test cases, given that the proba-
bilities were estimated using the train–train cases.
Since an exhaustive search through the entire power
set of the training variables is computationally
infeasible, we performed a forward stepping greedy
search [12]. That is, at each step of the search we
added the one variable that improved the perfor-
mance the most on the train–test set, until adding
any single variable did not improve performance.
Performance was measured as area under an ROC
curve.
The model selected 46 variables for prediction. The
entire set of variables included (in order of signiﬁcance)
is AGEPRES6, CPCO2, CBUN, ALERT, ALB, COU-
GHY, O2SATC, CHGB, HTNA, CVDA, INTUBATE,
CBPSYS, HEADACHY, COPDICUA, NOPNEPIS,
PTEDUC, CTEMPCCO, FEVERY, COBEFORY,
CXRINF, LASTDCDY, PULDULL, ASPEVENT,
LUNGOUTA, ASPLENA, FIO2ABG, FLUSHOT,
SEX, SWEATSY, CXREFFBL, FLU, UNSBLANA,
CPRESTIM, CURSPUTY, PRIATBRT, VALVDISA,
DMA, DIARRHEY, PTHISP, PNHOSPNO, ALC,
NEUTA, MENT4, BEFCPBRY, PSYCHDXA, and
PULFREM.4
Estimation of conditional probabilities was done
using parameter values a = 0 and b = 0; if NS0 ¼ 0, then
the conditional probabilities were taken to be uniform
(e.g., if f 0 is the state of a binary variable, then
P (f 0|S 0) = 0.5). Similarly, estimation of prior probabili-
ties was done using c = 0 and d = 0; if N = 0, then the
prior probabilities were taken to be uniform.
Table 1
A brief description of the predictive models evaluated in this paper
Model abbreviation Description
SB.D A simple Bayes model that uses just the 158 discrete variables.
SB.C A simple Bayes model that uses all 161 database variables, including 35 continuous variables.
SB.VS.D A simple Bayes model that uses 46 variables selected based on a greedy search procedure that attempted to ﬁnd the
most predictive set of discrete variables.
FM.D and FM.C Finite mixture models containing 158 discrete (FM.D) or 161 continuous and discrete (FM.C) variables.
FAN.D and FAN.C A model that combines a simple Bayes model with a ﬁnite mixture model. One version contains 158 discrete variables
(FAN.D) and the other contains 161 continuous and discrete variables (FAN.C).
RL.BS A rule-based system that uses the training set to tune various parameter thresholds that inﬂuence the rules being
learned. All 196 database variables are used.
LR.DIRE A logistic regression model that was developed using the PORT CAP database. It uses 102 database variables
(when trained on 1601 cases), with some of these variables continuous and some discrete.
NN.STL A neural network model constructed using traditional backpropagation methods. All 196 of the PORT CAP
database variables are included.
NN.MTLR A neural network model constructed using two new techniques. One technique involves learning to predict dire
outcomes by learning also to predict related outcomes. The other technique involves focusing on a learning measure
that is directly related to the area under the ROC curve. All 196 database variables are used.
Fig. 1. In the Simple Bayes model, the variables f1, . . ., fn, which
represent patient ﬁndings, are assumed conditionally independent
given the patient state variable S.
4 See Appendix A for the meaning of these variables.
350 G.F. Cooper et al. / Journal of Biomedical Informatics 38 (2005) 347–366
3.2. Finite Mixture (FM) and FAN models
This section describes the Finite Mixture and the
FAN models, as well as how we constructed several such
models.
The ﬁnite mixture (FM) model [13–15] is obtained by
using a discrete latent variable to model dependencies
among the ﬁndings and between the ﬁndings and the
outcome variable. That is, conditioned on the latent var-
iable, all the observable variables (ﬁndings and the out-
come) are assumed independent. A graphical
representation of a FM model is similar to the one for
the Simple Bayes model, with the only diﬀerence that
in a FM model the common parent is the latent variable
H rather than the outcome variable S, which is being
predicted (Fig. 2). The most important practical diﬀer-
ence with the simple Bayes model is that in FM the ﬁnd-
ings generally are not restricted to be conditionally
independent given the predicted variable S.
Learning an FM model from data consists of two
steps: (1) the determination of the number of values of
the latent variable, referred to as the cardinality of the
model; and (2) the estimation of the relevant prior and
conditional probabilities, in particular, the estimation
of the prior probability distribution of the latent vari-
able, and of the conditional probability distributions
of each ﬁnding and of the outcome variable, given the
latent variable.
The determination of the model cardinality is the
most diﬃcult computational step. We can formulate it
as a search problem, whereby a scoring function over
model cardinality of FM is deﬁned, and a search for
the model cardinality that maximizes the given score is
performed. A well established class of scores is based
on asymptotic approximations of the marginal likeli-
hood of the model, deﬁned as the probability
P (D | M) of the training set D given the model M. Intu-
itively, searching for the model that maximizes the mar-
ginal likelihood corresponds to searching for the model
that best ‘‘explains’’ the data. Scoring functions that can
be used include: (i) the Bayesian information criterion
(BIC); (ii) the Akaike information criterion (AIC); and
(iii) the Cheeseman–Stutz score (see [16] for a detailed
description of these scoring methods). These scoring
functions can be viewed as diﬀerent versions of ‘‘penal-
ized likelihood,’’ since they have the general form
P ðD jMÞ ¼ P ðD j h^;MÞ 
 penalty;
where h^ is the maximum likelihood estimator of the
parameters of the model, and penalty can in general be
interpreted as a term that penalizes model complexity
with its particular form diﬀering among the various
scoring functions.
The exact estimation of the parameters of the model
is computationally intractable because of the presence
of the latent variable. Therefore, approximate methods
need to be used. We use the Expectation Maximization
(EM) algorithm for this task [17,18]. The EM algo-
rithm is an iterative algorithm that is guaranteed to
converge to a local maximum. The EM algorithm for-
malizes a quite intuitive idea. Starting from some initial
parameterization of the model: (i) the values of the la-
tent variable are replaced by their expectation accord-
ing to the probability speciﬁed by the model; and (ii)
the new parameters are estimated based on the ‘‘com-
plete’’ data obtained by assuming that the missing data
are given by their estimated values. These two steps are
repeated until convergence to a local maximum is
reached. Notice that at each step, since (artiﬁcially)
complete data are available, parameter estimation for
FM is the same as parameter estimation for the Simple
Bayes model.
3.2.1. Summary of a model that combines the Finite
Mixture and simple Bayes models (FAN)
The Finite Mixture Augmented Naive Bayes (FAN)
model [11] is obtained by superimposing a ﬁnite mixture
model on the set of ﬁndings of a simple Bayes model
(Fig. 3). That is, given a Simple Bayes model deﬁned
over the outcome variable and the ﬁndings, a latent var-
iable is introduced to model the residual probabilistic
dependencies between the ﬁndings that are not captured
by the outcome variable. At the same time, in an at-
tempt to improve over the FM model, the FAN model
reduces the burden on the latent variable by modeling
part of the dependencies among ﬁndings through the
outcome variable. Notice that the Simple Bayes model
is subsumed by the FAN model, since it corresponds
to a FAN model with a one-valued latent variable.
Parameter estimation for a FAN model, as well as the
selection of the latent variables cardinality, are very
similar to the corresponding tasks for the FM model.
The only diﬀerence is that in the FAN model there are
two parent variables, the latent variable and the out-
come variable, on which to condition the probability
estimates of the ﬁndings.
Fig. 2. The Bayesian network structure used to represent a ﬁnite
mixture model, where H is a latent variable, S is an outcome variable,
and f1, . . ., fn are variables that represent patient ﬁndings.
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3.2.2. Induction of the Finite Mixture (FM) and FAN
models
In a manner parallel to the SB.C and SB.D model
induction described above, both continuous and discrete
versions of FM (FM.C and FM.D) and FAN (FAN.C
and FAN.D) were constructed. In all the experiments,
model selection (i.e., determining the number of values
of the latent variable) was based on a greedy step-for-
ward search that used BIC and AIC scores for ranking
models. In particular, given the set of models considered
in the search, the models were ranked according to the
BIC score and the AIC score, and the model that had
the best average rank over the two scores was selected.
3.3. Rule-based learning with bias search (RL.BS)
This section describes a method for rule-based learn-
ing with bias search (RL.BS), as well as howwe applied it.
3.3.1. Summary of rule-based learning with bias search
This section describes a rule learning system that
searches over various learning parameters in attempt-
ing to ﬁnd a set of rules that has good predictive per-
formance. In the machine learning ﬁeld, such a
procedure is known as bias search. We performed bias
search using version 5.5 of the RL rule learning system
[19,20].
The rules generated by RL are of the form: ‘‘if
f 0i and . . . and f
0
j then predict the patient state as S
0.’’
If a test case satisﬁes all of the features on the left-
hand-side of the rule (the if part), then the rule pre-
dicts the class speciﬁed by the right-hand-side of the
rule (the then part). As an example, the following rule
predicts that a patient will not experience a dire
outcome:
ifðage < 23Þ and ðpO2 > 48Þ then predict dire outcome
¼ no:
Rule strength is determined by a certainty factor (CF),
which is the following smoothed estimate of the positive
predictive value of the rule: (TP + 1)/(TP + FP + k),
where TP is the number of true positive predictions of
the rule on a training set, FP is the number of false po-
sitive predictions, and k is the number of values of the
variable being predicted (e.g., k = 2 for the binary dire
outcome variable).
RL selects rules using the following three criteria: (a)
the CF must be greater than the CF-thresh threshold
(e.g., CF-thresh = 0.6), (b) the number of cases covered
by the rule must exceed a threshold called min-POS, and
(c) every new rule must cover at least one new case not
covered by previous rules.
RL-bias-search (RL.BS) is an extension of the RL sys-
tem. RL.BS randomly divides the training data into
train–train (67%) and train–test (33%) datasets. The
train–train dataset is used to learn the rules using a se-
lected parameter setting (i.e., bias) and the train–test is
used to evaluate the performance of a learned rule set.
RL.BS explores various combinations of the CF-thresh
and min-POS settings in search of the settings that opti-
mize the predictive performance of the induced rule set;
the optimization criteria are discussed in the next para-
graph. The user speciﬁes theminimum andmaximum val-
ues for CF-thresh and min-POS, as well as the bias step
size, which is added to or subtracted from the CF- thresh
andmin-POS values of a selected pair of settings to create
new bias settings to evaluate. We used a simulated-an-
nealing algorithm [21] to generate newparameter settings;
for additional details about this approach, see [22]. The
search yields parameter settings that then are used to
learn a ﬁnal rule set from the entire set of training cases.
The ﬁnal rule set is used to make a prediction for a
case using a method called weighted voting. In weighted
voting, the rules matching a patient case are grouped
according to the state predicted by the rules (thus, for
a binary prediction problem, there will be two groups).
Then, the strengths of the rules (the rules CFs) of each
group are summed; each groups sum is the amount of
evidence provided for the state corresponding to the
group (therefore, for a binary prediction problem, this
yields two sums). The state with the largest amount of
evidence is then predicted as the class for that case.
For a given patient case, the probability of its state is
calculated as the evidence for the state of interest di-
vided by the total of the evidence given for all states.
For example, for a binary prediction with the states
S = A and S = B, if the sum of the CFs of the rules pre-
dicting state A is 350 and the sum of the CFs of the rules
predicting state B is 150, then the evidence for class A is
350, the evidence for class B is 150, and the estimate of
P (S = A|case ﬁndings) is 350/(350 + 150) = 0.7.
Fig. 3. The graphical representation of a FAN model.
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3.3.2. Induction of a rule-based model using bias search
(RL.BS)
All 196 of the pneumonia PORT variables were made
available for rule learning. For all of the experiments, we
used a parameter step size of 0.02. A parameter setting
was evaluated by running RL on the train–train dataset
using the setting, then evaluating the performance of the
rule set induced by RL on the train–test dataset. Using
the settings that yielded the best performance on the
train–test dataset, a ﬁnal model was induced from the
entire training set. This rule set was then applied to
the test set to evaluate the performance of the rules.
Using the training set containing all 1601 cases, the
induced rule set consisted of 35 rules that used the fol-
lowing 22 variables, which are listed in alphabetical or-
der: AGEPRES6, AGEPRESB, BPSYS, CBUN,
CGLU, CHCO3, CHGB, CNUMCOMO, CPCO2,
CPH, CPO2, CR, CRESPRAT, FIO2ABG, HEAD-
ACHY, KP, NUMSYM, PO2, PTEMPLOA, RTEMP,
SOXYGEN, and SWEATSY.
3.4. Logistic regression model
This section describes logistic regression models, as
well as how we constructed a particular model for use
in the studies reported here.
3.4.1. Summary of logistic regression
Logistic regression derives an equation of the follow-
ing form:
P ðSÞ ¼ e
ðb0þb1f1þb2f2þþbnfnÞ
1þ eðb0þb1f1þb2f2þþbnfnÞ ;
where S is a binary variable to be predicted, and
f1,f2, . . ., fn are discrete or continuous predictor variables
[23]. The constants b0,b1,b2, . . ., bn are estimated from
the training data, typically by using an iterative maxi-
mum likelihood technique. We can generalize the above
equation by including interaction terms in the sum,
which are composed of products of the fi variables.
3.4.2. Application of logistic regression to predict dire
outcomes (LR.DIRE)
LR.DIRE is a logistic regression model that we
trained on the PORT database in a way similar to
how the logistic regression model underlying the PSI
model was developed by Fine et al. [7] using an earlier
CAP database. Thus, LR.DIRE is closely related
(although not identical) to what would result if a PSI
model were constructed based on the PORT database.
The logistic regression models developed for the
experiments in this paper were all constructed using a
two step process. For each experiment, the predictor
variables were each run in a simple univariate regression
on the training dataset. Signiﬁcant variables, deﬁned as
those with p values of 0.05 or less for an F test, were then
entered into a multivariate logistic regression, which
also was built using the training set. We did not include
any interaction terms. To avoid strong covariate eﬀects,
variables measuring similar concepts were removed
based on the following rule: if a continuous variable
and its categorical counterpart were both signiﬁcant in
the univariate analysis, the one with the smaller p value
was used for the multivariate run; in cases where both
variables had the same value, the continuous version
was used.
Forward stepwise logistic regression was used for all
experiments. The analysis employed BMDP Dynamic,
v7.0 running on Windows NT 4.0. For the experiment
using 1200 training cases, the default BMDP settings
were used [24]. For experiments using 400, 800, and
1601 cases, some of the default parameter settings were
changed. These changes involved the p value limits for
entry and removal of terms into the model, and the total
number of times a term could be moved into or out of
the model (as well as some other minor changes). The
changes are noted below:
• Following the PSI model, AGEPRES (age of presen-
tation) and SEX were included the model at the start
of the forward stepping process and were not allowed
to be removed.
• All other terms (besides AGEPRES and SEX) were
allowed to move a maximum of two (2) times—either
entered or removed from the model a total of no
more than 2 moves.
• The following syntax was added to the ‘‘/Regression
paragraph’’: ENTER = 0.05, 0.04. REMOVE = 0.06,
0.05.
In addition to these changes, for the experiment with
1601 cases certain categorical variable codings were
reordered in the syntax such that baseline or ‘‘normal’’
values were represented by the initial entry. This was
to insure BMDP was comparing non-normal values to
the appropriate baseline value, since the software de-
notes the initial entry as the ‘‘normal’’ entry.
For the remainder of the experiments, the exact
parameters and methodology were used as listed above
(default settings plus three alterations).
The variables considered signiﬁcant from pass 1 (uni-
variate regression results, not shown here) were then en-
tered into the multivariate regression for pass 2, which
was run using a training set. The results of pass 2 for
the training set containing 1601 cases resulted in the fol-
lowing 102 variables being included in the model:
Discrete variables (n = 86):
FEVERY, RIA, COPDICUA, MUSKELA, NUTR-
STAA, RTEMP, ALERT, CPOLYS, CHGB, PTE-
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DUC, CNA, O2SATABG, CPO2, SOXYGEN,
CXRLOBES, CXRINFBL, COUGHY, SPUTB-
FOY, SWEATSY, CONFSDYY, MYALGIAY,
CADA, CVDA, CCOPDSEV, MIA, DNRA,
PTLIVLOA, MENT4, CBANDS, CPLT, CCR,
O2SATC, CPH, FIO2ABG, CO2RETEN, CXRC-
LOBE, COBEFORY, HEADACHY, COPDA,
CHFA, NTCAGEA, SVENTARA, DEMENTA,
CONFUSA, PTEMPLOA, FLUSHOT, CRES-
PRAT, PULCLEAR, CHCT, CHCO3, FIO2POX,
FIO2ABGA, CXREFF, BFPNSOBY, CHILLSY,
VENTARRA, BEFFATGY, ASPEVENT, PRIHO-
SPA, CBPSYS, INTUBATE, CPULSE,
CXREFFBL, HTNA, PULDULL, PTMRSTAA,
CPY, PULCYAN, CWEIGHT, DMA, THROT-
SOY, CPNHOSPN, SEX, PULRALES, PULDEC,
FEV15A, PULRHONC, ACTIVCAA, CANCERA,
PTRACEA, STEROIDA, CBPDIAS, HOMEO2A,
CXRINF, UNSBLANA, PULBRONC.
Continuous variables (n = 16):
LASTDCDY, RESPRATE, KP, O2SAT, AGE-
PRES, NUMCOMOR, WBC, GLU, SGOT, ALB,
NUMSYM, BUN, ALKPHOS, PCO2, LDH,
TEMPCCOR.
3.5. Artiﬁcial neural networks
In this section, we brieﬂy describe the standard feed
forward neural network model, as well as extensions
we used in the study reported here. We then describe
how we applied both the standard method and the newly
developed ones.
3.5.1. The standard neural network method (STL)
The standard approach to applying artiﬁcial neural
networks trained with backpropagation to problems
such as pneumonia risk prediction is to use sum-
squared-error (SSE) with ‘‘0’’ coding for ‘‘no dire out-
come’’ and ‘‘1’’ coding for ‘‘a dire outcome’’ as the
target values at the output of the network. This is super-
vised learning where the network learns to predict values
near zero for patients at low risk, and values near 1 for
patients at high risk.
Given a large training set, this method learns to predict
the probability of dire outcomes (instead of the Boolean
0/1 values it is trained on). When the training set is small,
however, the method will generally overﬁt the training set
and learn to output values near 0 and 1 for the cases it is
trained on. This yields low error on the training set, but
generalizes poorly to new cases in a test set.
Early stopping is a method that stops training the
neural network before it begins to overﬁt the training
data. This is done by examining the performance of
the network during training on an independent set of
cases. When performance on this set begins to worsen
(instead of continuing to improve), we assume the back-
prop network has begun overﬁtting the training data
and we stop training.
Early stopping requires that part of the training data
(the train–test dataset) not be used for training and be
held aside for testing to detect overﬁtting. This is unfor-
tunate because most learning methods train better with
more training data. Using a smaller training set (the
train–train dataset), because some of the training data
must be held aside to detect overﬁtting, can reduce
the performance of the trained backprop networks.
We use a simple form of model averaging to help mit-
igate this eﬀect. Suppose we have 1601 cases to use for
training. We use 75% of this data for training (the
train-train dataset), and 25% as the early stopping test
set (the train–test set). Thus we train the network on
1201 cases and test it on 400 cases to determine when
to stop training. A network trained this way is only
trained on 1201 cases, not the full 1601 cases available
for training. To reduce the negative impact of using a
smaller training set, we train 10 networks on training
sets of size 1201 instead of just one. Each network uses
a diﬀerent random sample of 1201 (from the 1601 avail-
able) cases as a train–train set (and thus also diﬀerent
samples of 400 cases as the train–test set.) After train-
ing all ten networks, each on somewhat diﬀerent
train–train sets, we combine the predictions of the ten
networks by averaging their predictions. This means
that the number of parameters in the ﬁnal model is
ten times the number of parameters in any one back-
prop network.
3.5.2. The rankprop technique
In this and the following sections, we describe two
new neural network learning techniques that we devel-
oped and combined [25].
In the experiments reported in this paper, the perfor-
mance criterion is the area under the ROC curve. ROC
area is a sort-based measure. It depends only on the
ordering it induces on the data, not on the particular va-
lue it predicts for any one case. But the sum-squared-er-
ror we used in the previous section is sensitive to the
values predicted for each case, not the ordering induced
on the data. We developed a method called Rankprop
that learns to rank patients by relative risk instead of
predict speciﬁc risk values for them.
The term Rankprop is short for ‘‘backpropagation
using sum of squares errors on estimated ranks.’’ The
basic idea of Rankprop is to rank (i.e., sort and then
number consecutively) the cases in the train-train set
based on the outcomes predicted, scale the ranks (we
scale uniformly to [0.25,0.75] with sigmoid output
units), and apply standard SSE backpropagation using
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scaled ranks as target values instead of using the 0/1 val-
ues in the train–train data.
Ideally, we would rank cases by the true frequency of
an outcome, such as dire outcome. Unfortunately, we do
not know the true frequencies. During training, all we
know is which patients in the training set had dire out-
comes. There are many possible sorts consistent with
these values. Which should backprop try to ﬁt? It is
the large number of possible sorts of the train–train
set that makes backpropagating ranks challenging.
Rankprop solves this problem by using the neural nets
model as it is being learned to order the train–train set
whenever target values are tied. In this database, where
there are many ties because there are only two target val-
ues, ﬁnding a proper ranking of the training set is a seri-
ous problem. Rankprop learns to adjust the target ranks
of the dataset at the same time it is learning to predict
ranks from that dataset.
To do so, Rankprop alternates between rank passes
and backprop passes. On the rank pass it records the
output of the network for each training pattern. It then
sorts the training patterns using the target values (0 or 1
for dire outcome), but using the networks predictions
for each pattern as a secondary sort key to break ties.
The basic idea is to ﬁnd the legal rank of the target val-
ues (0 or 1) maximally consistent with the ranks the cur-
rent model predicts. This closest matching ranking of
the target values is then used to deﬁne the target ranks
used on the next backprop pass through the training set.
Why might Rankprop be useful in learning a model?
We are given data from a target function f (x). Suppose
the goal is not to learn a model of f (x), but to learn to
sort patterns by f (x). Must we learn a model of f (x)
and use its predictions for sorting? No. It suﬃces to
learn a function g (x) such that for all x1, x2:
[g (x1) 6 g (x2)]) [f (x1) 6 f (x2)]. There can be many
such functions g (x) for a given f (x), and some of these
may be easier to learn than f (x). Rankprop tries to learn
simple functions that directly support ranking. One dif-
ﬁculty with this approach is that rankprop must learn a
ranking of the training data while also training the mod-
el to predict ranks. It is not yet known under what con-
ditions this parallel search will converge. We conjecture
that when rankprop does converge, it will yield simpler
models than it would have been learned from the origi-
nal target values (0/1), and that these simpler models
will often generalize better.
Another way of looking at this is to consider what a
traditional neural network trained with SSE on 0/1 tar-
gets tries to learn. If we were predicting mortality, for
example, it would attempt to drive the mortality predic-
tion for every patient who lived to a value of 0, and
every patient who died to a value of 1, regardless of their
(unknown) probability of death. Now compare this with
rankprop on the same database. Assume 90% of the pa-
tients lived and 10% died. Consider the patients who
survive. Rankprop does not have to drive all patients
that live to one ﬁxed value. Instead, it has to ﬁnd some
ordering of the patients that live. This means it is possi-
ble that the patients who live and have low probability
of death will be sorted to the left of patients who live
but have high(er) probability of death. The same is true
for patients who die. If such orderings can be found by
rankprop, the function that is to be learned should be
less nonlinear than the function that would have to be
learned by SSE on 0/1 targets.
3.5.3. The multitask learning technique
There are a number of attributes available in histori-
cal databases that are not suitable for use as inputs. For
example, the pneumonia PORT database contains vari-
ables such as the total cost of hospitalization and the
length of stay, as well as the values of the variables that
deﬁne dire outcome such as ICU admission for respira-
tory failure. It is inappropriate to use these attributes
as inputs when learning to predict risk because these val-
ues would never be available for future test cases when
risk prediction is to be done. They represent future
measurements.
Although these variables will not be available when
the model is used, it is possible to use the values of these
variables in the training set in ways that do not assume
that they will be available in the test set. Multitask learn-
ing (MTL) is one method of doing this. Multitask learn-
ing is a method that improves generalization
performance by having a learner simultaneously learn
many extra related tasks at the same time it learns to
make predictions for the main task. It does this parallel
learning while using a shared representation; what is
learned for each task can beneﬁt other tasks because
they share what is being learned.
In this application, we use MTL to beneﬁt from fu-
ture lab results and from any other future information
we have available about the training cases that could
be related to the dire outcome prediction task. These ex-
tra attribute values are used as extra backprop outputs
as shown in Fig. 4. The extra outputs bias the shared
hidden layer towards representations that better capture
important features of the domain. See [25–27] for details
about MTL and [28] for other ways of using extra out-
puts to bias learning.
It is beyond the scope of this paper to explain in de-
tail how MTL works. An example, however, will give an
intuition for what MTL does. The pneumonia PORT
database that we used contains an attribute that gives
the length of stay in the hospital (in days) for patients
who are hospitalized. In learning to predict the probabil-
ity of a dire outcome in patients with pneumonia, we use
this length of stay variable as an extra task for multitask
learning. Let us examine why learning to predict length
of stay might improve the ability to predict a dire out-
come as well. In general, we expect patients with low
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risk of a dire outcome to not experience a dire outcome
(dire outcome = 0), and patients at high risk to have dire
outcome = 1. But some patients that are high risk will
have dire outcome = 0, and some patients that are low
risk will have dire outcome = 1. This happens because
dire outcome is the outcome itself, not the underlying
probability of the outcome. Unfortunately, we have no
direct measure of a patients probability of dire outcome.
We only see the Boolean outcome.
This is where learning to predict length of stay can
help. A patients length of stay is related to their risk.
A patient who stays in the hospital for a long time
presumably is at greater risk than a patient who stays
in the hospital a short time (ignoring patients who die
after a short stay). If we train an artiﬁcial neural net-
work to predict length of stay, some of what it learns
may help it create intermediate assessments of patient
risk for a dire outcome. Since the network shares
what it learns for the length of stay task with the
main risk prediction task (dire outcome), some of this
shared assessment may help the network to learn to
better diﬀerentiate intermediate risks of dire outcome.
This learning of related tasks, which can inform the
main task, is the central idea behind multitask
learning.
3.5.4. Application of the STL and MTLR methods
We applied two diﬀerent neural network methods to
the experiments with the PORT database. The ﬁrst the
standard learning method (STL) uses traditional sum-
squared-error on 0/1 targets. The second method uses
Multitask and Learning along with Rankprop learning
(MTLR). For MTLR, we used the following variables
as extra outputs for neural network training:
type of care (outpatient versus inpatient)
whether detailed baseline data were collected (y/n)
whether proxy respondent provided baseline data
(y/n)
regression model risk based on baseline data
3-level risk score, derived from the regression model
5-level risk score, derived from the regression model
count of cardiologic morbid complications
count of central nervous systemmorbid complications
count of dermatologic or allergic morbid complications
count of gastrointestinal morbid complications
count of hematologic morbid complications
count of liver morbid complications
count of pulmonary morbid complications
count of renal morbid complications
count of suppurative morbid complications
count of total morbid complications
discretized count of total morbid complications
count of total severe morbid complications
count of bothersome symptoms
count of missing values of bothersome symptoms
ICU care or telemetry
reason for ICU admission
length of stay for hospitalized patients
discrete version of length of stay
total patient hospital cost
discretized version of total patient hospital cost
days to return to daily household activities
discretized version of days to return to daily house-
hold activities
With both methods we trained on 75% of the training
data and used the remaining 25% of the training data for
early stopping. To reduce the negative impact of train-
Fig. 4. A hypothetical example of a neural network that can be applied to predict dire outcomes. The network is trained with outcomes that are
plausibly related to a dire outcome, including in this example: length of hospital stay, days in the ICU, and total hospital costs.
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ing on less data, we average the predictions of ten net-
works, each of which was trained on a randomly chosen
75% sample of the training set. In all experiments we
used all 196 variables as inputs.
We trained the networks with standard gradient des-
cent using the Aspirin/Migraines Neural Network Sim-
ulator developed by Mitre Group. The backprop
networks we used for all our experiments have 64 hidden
units, sigmoidal hidden and output units, and are fully
connected at the input-to-hidden and the hidden-to-out-
put layers. There were 15,104 weights per network. A
momentum of 0.9 and learning rate of 0.1 were applied.
Networks were trained a maximum of 100 epochs, but
early stopping often selected models trained with 25–
75 epochs.
4. Experimental methodology
In this section, we describe the training and test data-
sets we used, as well as the evaluation measures.
4.1. Training and test datasets
A training (derivation) set of 1601 patient cases (70%)
was created by randomly sampling from the 2287 CAP
patients in the pneumonia PORT database. The follow-
ing size training subsets were created by using the ﬁrst n
cases from a list of the 1601 cases: 100, 200, 400, 800,
1200, and 1601. Missing data were ﬁlled-in using an iter-
ated k-nearest neighbor method, which is described in
Appendix C.
A test (validation) set of size 2287 
 1601 = 686 was
used for the evaluation. For each of the six training sets,
the method used to ﬁll in missing data in that training
set also was used to ﬁll-in data in a corresponding test
set. Thus, there were six versions of the test dataset, cor-
responding to the six training sets mentioned above.
4.2. Evaluation measures
The primary measure we used in comparing the 11
models described in Section 3 is the area under the
ROC curve, which is a common measure for comparing
the discriminative performance of models [29–31]. An
area of 1 corresponds to perfect prediction of dire out-
come for the cases in the test set. An area of 0.5 corre-
sponds to random guessing of the probability of dire
outcome for each case in the test set.
We analyzed in detail the performance of
NN.MTLR, which had the highest ROC curve area
among the 11 models. To assess performance diﬀerences
at particular points on the ROC curve, one of us (author
MJF, whose clinical research focus includes CAP) as-
sessed a range of probability thresholds of dire out-
comes that he believes to be clinically relevant in
inﬂuencing decisions about where to treat CAP patients.
This range spanned from 1 to 5%. We identiﬁed a point
on the ROC curve for NN.MTLR that was close to the
1% threshold; more speciﬁcally, at that point on the
curve, for the test set of patient cases recommended by
NN.MTLR for home treatment, about 1% (more pre-
cisely, 1.3%) experienced dire outcomes.5
5. Results and discussion
We ﬁrst describe the predictive performance of the
models we constructed for this study. Next, we analyze
the best performing model.
5.1. Predictive performance of the constructed models
Of the 686 CAP patients in the test set, 79 (11.5%)
experienced a dire outcome. Table 2 subdivides the 79
cases to show more speciﬁcally why the dire outcomes
occurred. The table indicates that the most common
cause of a dire outcome was admission to the ICU
(for respiratory failure, respiratory or cardiac arrest,
or shock/hypotension). Only 20% of the dire outcomes
were due to death alone, while an additional 23% were
due to death plus another dire event. Fifty-seven percent
of the dire outcomes were for reasons that did not in-
clude death. The fact that the majority of the dire out-
come cases had a non-mortality outcome suggests that
predicting mortality is not a good surrogate for predict-
ing dire outcomes more broadly. It seems likely that a
clinical decision about where to treat a CAP patient
(inpatient versus outpatient) would be inﬂuenced by
concern about multiple types of clinical dire outcomes,
not just death. This line of reasoning supports the
importance having a model that predicts dire outcomes
more broadly than mortality.
In Table 3, for each system and training set size, the
area under the ROC curve is shown. For 1601 training
cases, the bold entry for NN.MTLR indicates that it
has the highest ROC area. For the models constructed
from 1601 training cases, an asterisk indicates that a
comparison of its ROC area with NN.MTLR has a
two-sided p value that is less than 0.05, suggesting that
NN.MTLR performed better. We used the method de-
scribed by Hanley and McNeil to perform these statisti-
cal tests [32].
Fig. 5 shows the models from Table 3 that have ROC
curve areas that are not statistically diﬀerent (at the 0.05
level) from those of the best model (NN.MTLR). Fig. 6
shows the results of the remaining methods from Table 3
that are statistically signiﬁcantly worse than
5 We assume that CAP patients with a probability of death (at 30
days) below 1.3% would likely be treated at home, unless there were
extenuating circumstances.
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NN.MTLR. Interestingly, four of these ﬁve models do
not improve monotonically as a function of the training
set size. The reasons for these non-monotonic patterns
will require further study. For example, it could be that
the method of variable selection in LR.DIRE led to its
decreased performance when using 1601 training cases.
Most of the 11 models are close to their peak perfor-
mance after only 400 training cases. The NN.MTLR
and SB.D models attain close to their best performance
after only 200 training cases. The asymptotic character
of the curves in Figs. 5 and 6 suggests that the addition
of further training cases beyond 1601 is not likely to im-
prove the models predictive performance appreciably.
Fig. 5. The ROC curve areas for the models that perform the best when using 1601 training cases.
Table 3
The area under the ROC curve for predicting a dire outcome as a function of the modeling methodology and the training set size
100 200 400 800 1200 1601
FAN.C 0.690 0.724 0.766 0.756 0.771 0.814*
FAN.D 0.831 0.819 0.805 0.820 0.838 0.849
FMM.C 0.773 0.722 0.780 0.810 0.812 0.815*
FMM.D 0.840 0.827 0.821 0.783 0.784 0.813*
LR.DIRE — — 0.818 0.829 0.828 0.774*
NN.MTLR 0.830 0.848 0.836 0.862 0.866 0.863
NN.STL 0.726 0.828 0.829 0.834 0.848 0.854
RL.BS 0.726 0.765 0.814 0.839 0.823 0.851
SB.C 0.754 0.790 0.833 0.815 0.850 0.854
SB.D 0.831 0.838 0.843 0.850 0.854 0.851
SB.VS.D 0.529 0.708 0.745 0.769 0.806 0.809*
Entries in bold represent the best performance for a given training set size. For 1601 training cases, asterisks indicate that the performance of a model
is signiﬁcantly worse (see text) than the best performing model (NN.MTLR). We were not able to obtain acceptable convergence for LR.DIRE with
only 100 or 200 cases, and therefore, its performance is not reported for these training set sizes.
Table 2
The 79 cases of dire outcomes in the test set are subdivided into seven
diﬀerent classes
Severe complications Death Admission to ICU Number of
patient cases
No No Yes 27 (34%)
No Yes No 16 (20%)
No Yes Yes 3 (4%)
Yes No No 14 (18%)
Yes No Yes 4 (5%)
Yes Yes No 12 (15%)
Yes Yes Ues 3 (4%)
Each class describes a joint set of conditions that constitute a dire
outcome.
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With 1601 training cases, the mean diﬀerence in ROC
curve area between the models in Fig. 5 and those in
Fig. 6 is 0.8535 
 0.8049 = 0.0486. Although this diﬀer-
ence may seem inconsequential, we discuss below how
small (but real) diﬀerences in predictive performance
can have major implications for healthcare delivery.
5.2. Analyzing the predictive performance of NN.MTLR
In this section, we analyze the predictive performance
of the NN.MTLR model, which for brevity we call NN.
The NN model was the best predictor of dire outcomes
we found when using the full 1601 training cases. We
examine its predictions to gain insight into how well it
might perform as an aid to clinicians making decisions
about where to treat CAP patients. In particular, we
are interested in estimating the impact the NN model
might have on CAP patient quality of care and health-
care costs, if the decisions about where to treat the pa-
tients (home versus hospital) were based on the
models predictions. We emphasize that the results of
this analysis are preliminary.
Fig. 7 shows the ROC curve for the NN model ap-
plied to the 686 test cases. This NN model was trained
with 1601 cases to predict a dire outcome, as deﬁned in
Appendix B. The true positive rates and false positive
rates for the curve are based on whether or not a dire
outcome was predicted to occur, given whether or not
a patient actually experienced a dire outcome. The area
under the ROC curve is 0.863. In terms of clinical prac-
ticality, however, only a portion of the ROC curve is rel-
evant to making a decision about whether to admit a
CAP patient. In the remainder of Section 5.2 we focus
our analysis on a relevant portion of the NN ROC
curve. In doing so, for the purpose of analysis, we
Fig. 6. The ROC curve areas for the models that perform signiﬁcantly worse than the best method (NN.MTLR) when using 1601 training cases.
Fig. 7. ROC curve for the prediction by NN of a dire outcome in each
of 686 test cases of patients with CAP. The large black dot indicates
the point on the curve (tpr = 0.937 and fpr = 0.359) that is discussed in
detail in the text.
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assume that those patients predicted by NN not to have
a dire outcome would be treated at home, and the pa-
tients predicted to have a dire outcome would be admit-
ted to the hospital.
5.2.1. Predictive performance at a speciﬁc point on the
ROC curve
In this section, we examine the point on the ROC
curve in Fig. 7 at which approximately 1.3% of the test
cases predicted by NN to not have a dire outcome in fact
had a dire outcome. We call this percentage the error
rate. At this 1.3% error rate, NN has a true positive rate
(tpr) of 0.937 and a false positive rate (fpr) of 0.359 (see
Fig. 7). At that point on the ROC curve, NN recom-
mends treating at home 394 patient cases (because they
are predicted not to have a dire outcome), and of those,
a total of ﬁve patients (1.3% [0.17%,2.37%]) subse-
quently developed a dire outcome, where the 95% conﬁ-
dence interval is shown in square brackets. Based on the
care actually received, 280 patients were treated at
home, and of those, a total of ﬁve patients (1.8%
[0.25%,3.33%]) developed a dire outcome. The diﬀer-
ence between the 1.3% error rate by NN and the 1.8%
error rate of the actual treatment is not statistically sig-
niﬁcant (p = 0.29). We discuss these error rates further
in Section 5.2.3.
At the ROC point described in the previous para-
graph, the NN model recommends admitting fewer pa-
tients to the hospital than were admitted in actual
practice. In particular, the model recommends admitting
292 of the 686 test patients (42.6%), while 406 (59.2%) of
the 686 cases were actually admitted to the hospital.
Thus, the NN model recommended admitting about
16.6% fewer (of the total 686 cases) than were actually
admitted, which is a highly statistically signiﬁcant diﬀer-
ence (p < 0.0001). In the next section, we estimate the
cost savings that might result from such a reduction in
admissions.
5.2.2. Estimated cost savings
In this section, we estimate the dollar-cost savings of
using the NN to inform decisions about whether to treat
CAP patients at home (outpatients) or in the hospital
(inpatients). To do so, we must introduce several
assumptions, which we make explicit. The validity of
these assumptions, as well as the accuracy of the esti-
mates of the performance of NN, are issues that will re-
quire further evaluation. Nonetheless, we believe the
analysis below provides insight. In particular, the analy-
sis highlights that even small improvements in predictive
performance can have signiﬁcant, positive healthcare
consequences.
We focus our analysis on CAP patients in the US
who were seen in the ED, because most of the pneumo-
nia PORT patients (upon which we base on analysis)
were seen in the ED. From 1993 to 1995, the average
annual number of CAP visits was about 4,487,000, of
which about 1,256,000 (28%) occurred at emergency
departments [34]. Since we conﬁne our analysis to
CAP patients seen in the ED, our analysis will tend to
underestimate the total national impact of a given strat-
egy. Nonetheless, we believe that an analysis for this
important subset of patients is informative.
As described in Section 5.2.1, the NN model is ex-
pected to recommend 16.6% fewer admissions (when
used as a decision aid for the 1,256,000 CAP patient-
cases seen in the ED) than the treatment actually used
(42.6% vs. 59.2%). The estimated cost of an inpatient
CAP case in the US in 1994 was $7517,whereas the high-
est estimated cost of an outpatient case was just $421[5].
Thus, the diﬀerence in cost is $7517 
 $421 = $7096. If
the use of the NN recommendations translated into
1,256,000 · 16.6% fewer CAP admissions (than the
admissions expected to occur without using a decision
model), then the expected savings of following those rec-
ommendations would be 1,256,000 · 0.166 · $7096 =
$1.479 billion (in 1994 dollars).
More generally, viewed as a function of the percent-
age decrease in admissions, the US national cost savings
would be about 1,256,000 · 0.01 · $7096 = 89 million
dollars per percent decrease in hospital admissions of
CAP patients seen in emergency departments. If such
a decrease in admissions could be achieved while not
increasing the number dire outcomes that occur in pa-
tients treated at home, the overall impact would be po-
sitive and signiﬁcant. This perspective highlights that even
small (but real) improvements in predictive modeling may
lead to enormous healthcare cost savings. Therefore, the
development of better predictive models is an undertaking
of considerable importance.
We conclude this section with a discussion of the ma-
jor assumptions on which the above cost analyses are
based.
• For each patient recommended to be treated at home by
some model M according to decision threshold t, if he/
she had been so treated then his/her dire outcome status
would have been the same as the outcome he/she actu-
ally experienced, even if he/she was actually admitted.
This assumption is made more tenable by the use of a
decision threshold near one percent, in which only very
low risk patients were being recommended for treatment
at home by a model. Also, the NN model controlled for
numerous patient covariates that might otherwise con-
found the relationship between place-of-treatment and
dire outcome status. In related research, a controlled
trial involving 1743 patients with CAP showed that
the availability to clinicians of the output of a mortali-
ty-prediction model ‘‘reduced the use of institutional re-
sources without causing adverse eﬀects on the well-being
of patients’’ [33].
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We make an analogous assumption to the one above
for patients recommended to be treated in the hospital.
• Patients in emergency departments throughout the US
would experience similar results to those found in this
analysis, which is based on data from a small set of
US and Canadian hospitals. The patient base used here
has a higher fraction of patients who were seen at aca-
demic medical centers than does the US pneumonia
population at large. Attenuating somewhat this con-
cern about possible population heterogeniety, Fine et
al. [7] found that the PSI mortality risk model, which
was constructed using data from a wide mix of 78
US hospitals, generalized well in predicting mortality
of the 2287 patients in pneumonia PORT dataset.
• The predictions of a model would be readily available
and heeded. It could well be that clinicians would
appropriately (or inappropriately) ignore some of a
models predictions. It could also be that the treat-
ment decision is based on multiple decision makers
in addition to the treating clinician, including the
patient and his or her family.
• The ﬁnancial and time costs of having and using a pre-
dictive model are negligible. Such a model might be a
part of a larger clinical information system that serves
many other purposes. Thus, the incremental cost of
making the model available for clinical use could be
relatively small. In particular, it likely will be impor-
tant that the predictor variables in a predictive model
be available in electronic health records, which are
populated with information as part of the normal
workﬂow of healthcare delivery; current trends make
this scenario seem plausible in the next 10–15 years.
• There are no hidden health-quality costs in using the
model. For example, we assume that by using a
model, a physicians own clinical skills would not
decrease over time, thereby possibly decreasing
patient quality of care.
Almost certainly, the above assumptions do not hold
exactly. We therefore emphasize that the results in Sec-
tion 5.2 are preliminary and suggestive, but by no means
conclusive. Ultimately, the overall clinical and monetary
impact of a given predictive model will need to be vali-
dated by experimental study. The preliminary analyses
in this paper suggest that such studies, if carefully de-
signed, may be well worthwhile.
5.2.3. A preliminary analysis of the impact on quality of
care
Monetary cost savings are appropriate only if they do
not decrease the overall quality of health care. We
would like to develop predictive models that decrease
cost and increase quality of care. While the present
study does not address this important issue in detail,
we provide the following relevant analyses.
Plausibly the most negative outcome is for a CAP pa-
tient to be sent home for treatment and subsequently
experience a dire outcome. As mentioned above, of the
280 patients actually treated at home, only 5 (1.8%)
experienced a dire outcome. Home treatment was rec-
ommended for 394 patient cases by NN, and also only
5 patients (1.3%) experienced a dire outcome. Thus, by
this measure, the models recommendations are not be
expected to decrease the quality of health care.6
As mentioned, 1.8% of the patients actually treated at
home experienced a dire outcome. We examined the out-
comes of those patients who in reality were treated at
home, but for which the NN model recommended treat-
ment in the hospital; in doing so, we used the tpr and fpr
described in Section 5.2.1, which corresponds to an error
rate of 1.3%. There were 18 such cases, of which 3
(16.7%) had a dire outcome, which is a 9.3-fold increase
in risk over the 1.8% risk for the total population of pa-
tients actually treated at home. These results suggest
that using the NN models recommendations might im-
prove the quality of care for some high-risk patients who
otherwise would be treated at home. It is possible, how-
ever, that some or all of these patients would prefer to be
treated at home.
6. Summary and conclusions
On a training and test dataset of CAP patients, we
found that there were statistically signiﬁcant diﬀerences
in how well diﬀerent induced models predicted dire out-
comes. After approximately 400 training cases, there
was little improvement in the ROC area for most of
the models induced by most of the methods. Thus, the
results appear stable in the large training sample limit.
It will be useful to validate these results by testing
whether randomly re-sampling subsets of the 1601 train-
ing cases leads to similar asymptotic patterns of predic-
tive performance.
An innovative neural network learning method in-
duced a model (NN.MTLR) that had the largest ROC
area when using all the training cases; statistically, its
performance was signiﬁcantly diﬀerent from ﬁve models
constructed using other methods, and not signiﬁcantly
diﬀerent from ﬁve other models. Additional research
will be required to determine whether other machine-
learning methods that were not tested in our investiga-
tion might perform even better than this neural network
model.
6 Of the 394 patients recommended for home treatment by NN, 132
were actually treated in the hospital. We do not know what the dire
outcome status of these inpatients would have been, had they been
treated at home. As discussed in Section 5.2.2, we assume that the dire
outcome status of these low-risk patients would have been the same
with home treatment as the actual outcomes they experienced in the
hospital.
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Our study does not provide direct evidence for how
NN.MTLR would perform on other clinical prediction
problems; rather, it focuses speciﬁcally on ﬁnding a
good predictor of a dire outcome in CAP patients. Also,
additional research is needed to validate the dire-out-
come predictive performance between NN.MTLR and
other methods and to determine with conﬁdence the rea-
sons for those diﬀerences.
The paper presents a preliminary analysis that sup-
ports that the predictive performance of NN.MTLR
could—under assumptions—yield a substantial decrease
in the cost of healthcare delivery without any decrease
in healthcare quality. The data needed to construct
and apply NN.MTLR are not yet readily available in
electronic health records. We believe it plausible, how-
ever, that such data will be electronically available in
the next 10–15 years. As such data are increasingly cap-
tured in electronic form, the number of local patient
cases available for model induction and the clinical cov-
erage of those cases will increase dramatically. Further-
more, in time, we can expect that patient outcomes will
be measured in increasing detail, thus making it feasible
to model complex outcomes of interest, such as a dire
outcome. It will therefore become more and more feasi-
ble to routinely construct detailed predictive models,
such as NN.MTLR, which are based on local patient
data. More generally, the induction of such models
might use both national data (for its large sample size)
and local data (for its ability to locally tailor models).
Once constructed, such models could be applied seam-
lessly to make predictions on new local cases.
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Appendix A. A list of the variables in the pneumonia
PORT database that were used in the present study
An alphabetized listing of the baseline clinical vari-
ables contained in the pneumonia PORT database are
listed below. Each variable name is followed by a brief
description.
The term categ indicates that a variable is a categor-
ical (i.e., discretized) version of a continuous variable.
The categories were created based on clinical judgment
of pneumonia specialists on the pneumonia PORT re-
search project.
ABPAINY
ACTIVCAA
abdominal pain y/n
active cancer at presentation
AGEPRES age at presentation
AGEPRES6 (categ) age at presentation
AGEPRESB (categ) age at presentation
ALB albumin g/dl
ALC alcohol abuse (new or old)
ALERT alertness
ALKPHOS alkaline phosphatase IU/L
ALLATBXR allergic antibiotics y/n
ANOREXIY loss of appetite y/n
ASMAICUA asthma ICU admission past year
ASPEVENT aspiration event
ASPLENA splenectomy
ASTHMAA asthma
BANDS wbc diﬀerential percent bands
BEFCPBRY chest pain y/n before admission
BEFFATGY fatigue retro y/n before admission
BFPNSOBY shortness of breath y/n before admission
BILIR total bilirubin mg/dl
BPDIAS diastolic blood pressure mm hg
BPSYS systolic blood pressure mm hg
BUN blood urea nitrogen mg/dl
CADA coronary artery disease
CALB (categ) albumin
CALKPHOS (categ) alkaline phosphatase
CANCERA ever had cancer
CBANDS (categ) wbc % bands
CBILIR (categ) total bilirubin
CBPDIAS (categ) diastolic blood pressure
CBPSYS (categ) systolic blood pressure
CBUN (categ) blood urea nitrogen
CCOPDSEV (categ) copd severity
CCR (categ) creatinine
CFATGY fatigue y/n
CGLU (categ) glucose
CHCO3 (categ) HCO3
CHCT (categ) hematocrit
CHFA congestive heart failure
CHGB (categ) hemoglobin
CHILLSY chills y/n
CKP (categ) potassium
CLASTDCD (categ) days since last discharge
CLDH (categ) ldh lactic dehydrogenase
CNA (categ) sodium
CNOPNEPI (categ) number prior episodes
pneumonia
CNUMCOMO (categ) number of comorbid conditions
(exc. HTN)
CNUMSYM (categ) number of symptoms
CO2RETA copd CO2 retainer
CO2RETEN CO2 retention
COBEFORY cough retro y/n before admission
CONFSDYY confusion y/n
CONFUSA confusion noted in chart
COPDA chronic obstructive pulmonary disease
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COPDICUA copd icu admission
COPDSEV copd severity
COUGHY cough y/n
CPCO2 (categ) pCO2
CPH (categ) arterial pH
CPLT (categ) platelet count
CPNHOSPN (categ) number of prior
hospitalizations for pneumonia
CPO2 (categ) PO2
CPOLYS (categ) wbc % polys
CPRESTIM (categ) time at presentation
CPULSE (categ) heart rate beats per minute
CPY chest pain y/n
CR creatinine mg/dl
CRESPRAT (categ) respiratory rate breaths/min
CSGOT (categ) sgot ast
CSOBY shortness of breath y/n
CSTERDUR (categ) steriod duration
CTEMPC (categ) temperature centigrade
CTEMPCCO (categ) temperature corrected
CURSPUTY sputum y/n
CVDA cerebrovascular disease
CWBC (categ) wbc
CWEIGHT (categ) weight
CWTLOSS weight loss—y/n/missing
CXRCLOBE (categ) number of lobes involved
CXREFF pleural eﬀusion
CXREFFBL bilateral pleural eﬀusion
CXRINF radiographic evidence of
pneumonia (inﬁltrate)
CXRINFBL bilateral inﬁltrate
CXRLOBES number of lobes involved
CXRPRCNT max % of involvement of a single lobe
CXRTYPE type of inﬁltrate
DEMENTA prior md documented dementia
DIARRHEY diarrhea y/n
DMA diabetes mellitus
DNRA dnr status
DYMDSYM days from ﬁrst seeing an MD to
presentation to study
FEV15A copd fev1 <1 L
FEVERY fever y/n
FIO2ABG FiO2 at time of abg
FIO2ABGA FiO2 at time of abg
FIO2POX pulse oximetry FiO2
FLU ﬂu 6 weeks prior to presentation
FLUSHOT ﬂu shot in past year
GLU glucose mg/dl
HCO3 HCO3 meq/L
HCT hematocrit %
HEADACHY headache y/n
HEMOPTY coughing up blood y/n
HGB hemoglobin g/dl
HOMEO2A copd chronic home O2 user
HTNA hypertension
HYPOAMA hypogammaglobulinemia
IMMSUPP1 ‘‘immunosuppression1 (y/n) includes:
NEUTA,HYPOAMA, ASPLENA’’
IMMSUPP2
INSTLUNA
‘‘immunosuppression2 (y/n) includes:
IMMSUPP1, MYEL90A, TRANSPA,
STERHDC’’
interstitial restrictive lung
INTUBATE patient intubated
IVDRUGA IV drug use
KP potassium meq/L
LASTDCDY days since most recent hospital discharge
LDH ldh lactic dehydrogenase IU/L
LIVERDIA liver disease
LUNGOUTA pneumonectomy
MENT4 mental status questionnaire-4 levels
MENTSTAT mental status questionnaire
MIA myocardial infarction
MUSKELA musculoskeletal problems
MYALGIAY muscle pain y/n
MYEL90A myelosuppressive drugs past 90 days
NA sodium meq/L
NAUSEAY nausea y/n
NEUTA neutropenia
NOPNEPIS number prior episodes pneumonia
NTCAGEA neuromuscular thoracic cage disorder
NUMCOMOR number of comorbid conditions;
includes:
NUMIMMUN number of factors for
immunosuppression
NUMSYM number of symptoms
NUTRSTAA documented poor nutrional status or
malutrition
O2SAT O2 saturation pulse oximetry %
O2SATABG which done ﬁrst (ABG or pulse ox)
O2SATC (categ) O2SAT
PCO2 pCO2 mmHg
PH arterial pH
PLT platelet count ·103/ll
PNEUVACC ever had vaccination for pneumonia
PNHOSPNO number of prior hospitalizations for
pneumonia
PO2 pO2 mmhg
POLYCA copd polycythemia
POLYS wbc diﬀerential percent polys
PREG patient pregnant
PRESTIME time at presentation—hours
PRIATBNM number of prior antibiotics
PRIATBRT route of prior antibiotics
PRIATBXA antibiotic 30 days prior present
PRIHOSPA prior hospitalization 30 days
PSYCHDXA formal psychiatric diagnosis
PTEDUC patient education
PTEMPLOA current employment status
PTHISP pt hispanic descent or origin
PTLIVLOA living arrangements
PTMRSTAA marital status
PTRACE pt racial background
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PTRACEA pt racial background (white/non-white)
PULBRONC bronchial breath sounds
PULCLEAR lungs clear
PULCYAN cyanosis
PULDEC decreased breath sounds
PULDULL dullnes to percussion
PULETOA E to A changes
PULFREM fremitus
PULMHTNA copd pulmonary hypertension
PULRALES rales
PULRHONC rhonchi
PULSE heart rate beats per minute
PULWHEEZ wheezing
RESPRATE respiratory rate breaths minute
RIA chronic renal insuﬃciency
RTEMP route temperature centigrade
SEX sex of patient
SGOT sgot ast IU/L
SMOKE does patient smoke tobacco
SOXYGEN pO2 < 60 or O2sat < 90
SPUTBFOY sputum retro y/n before admission
STBLANGA chronic stable angina
STERDUR corticosteroids yes number of days
STERHDC high-dose chronic corticosteroids
STEROIDA corticosteroids past 90 days
SVENTARA dysrhythmias supraventricular
SWALLDIA swallowing disorders
SWEATSY sweats y/n
SZA seizures
TEMPC temperature centigrade
TEMPCCOR temp deg C corrected
(for oral/rectal/axillary)
THROTSOY sore throat y/n
TRANSPA transplant y/n (solid organ transplant)
UNEATY unable to eat y/n
UNSBLANA unstable angina
VALVDISA valvular disease
VENTARRA dysrhythmias ventricular
VOMITY vomiting y/n
WBC white blood cell count · 1000/ll
WEIGHT weight in pounds
Appendix B. A detailed deﬁnition of dire outcome
In the text that follows, a number in square brackets
denotes the integer used in the pneumonia PORT data-
base to encode the variable value that immediately fol-
lows the brackets. An alphabetic label in square
brackets denotes a variable name.
A dire outcome is deﬁned as having been present if one
or more of the following three events occurred with a
patient:
(1) death within 30 days of presentation
[DEAD30PR]: [1] yes
(2) an initial ICU admission for one or more of the
following three reasons:
• respiratory failure [RESPFALI]: [1] documented
as reason for the ﬁrst admission
• respiratory or cardiac arrest [CARRESTI]: [1]
documented as reason for the ﬁrst admission
• shock/hypotension [SHOCKI]: [1] documented
as reason for the ﬁrst admission
(3) the presence of one or more of the following severe
complications:
• bleed at site of procedure [BLEEDI]: [4] vascular
repair or >2 units of packed red blood cells
• congestive heart failure [CHFI]: [3] new or wors-
ening CHF or pulmonary edema with intubation
• IV site phlebitis [IVSITEI]: [4] requiring
surgery
• pulmonary embolus [PULEMBI]: [1] pO2 P 60or
no pO2 done, or [2] with hypoxemia (pO2 < 60), or
[3] with hypotension
• myocardial infarction [INFARCI]: [1] subendo-
cardial, or [2] transmural without arrhythmias
or CHF, or [3] transmural with arrhythmias or
CHF
• shock [CSHOCKI]: [2] hypotension requiring
pressors or IABP
• ventricular tachycardia or ﬁbrillation [VTA-
CHYI]: [3] new onset or worsening of V-tach
with syncope, chest pain or hypotension
• cardiac/respiratory arrest [CARDIACI]: [1] suc-
cessful resuscitation, or [2] unsuccessful resusci-
tation (patient expired), or [3] no resuscitation
performed (patient expired)
• cerebrovascular [CEREBI]: [2] new stroke with no
deﬁcits, or [3] new stroke with neurological deﬁcits
• encephalopathy [ENCEPHI]: [3] coma
• other allergy [OTALEGYI]: [3] systemic
anaphylaxis
• gastrointestinal bleeding [GBLEEDI]: [4] new or
worsening and required 3–4 units of blood, or (5)
new and worsening and required >4 U of blood
• anemia [HEMANEI]: [5] Hct < 20
• leukopenia [LEUKI]: [4] WBC < 1000
• thrombocytopenia [THROMI]: [4] <50 K
• pneumothorax [PNTHRXI]: [2] treated with
chest tube, or [3] tension pneumothorax
• respiratory failure [PULFAILI]: [3] intubated
with PEEP 6 5 mm, or [4] ARDS or intubated
with PEEP >5 mm
• renal insuﬃciency [RENALINI]: [3] new or wo-
rsening and requiring dialysis or transplant
• urinary tract infection [UTII]: [4] urosepsis with
positive blood cultures
• brain abscess/parameningeal focus [BRABSCI]:
[1] present at presentation or [2] developed after
presentation
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• empyema [EMPYI]: [1] present at presentation
or [2] developed after presentation
• endocarditis [ENDOI]: [1] present at presenta-
tion or [2] developed after presentation
• meningitis [MENINGI]: [1] present at presenta-
tion or [2] developed after presentation
• osteomyelitis [OSTEOMI]: [1] present at presen-
tation or [2] developed after presentation
• septic arthritis [SEPARTI]: [1] present at presen-
tation or [2] developed after presentation
• line-related sepsis [LINESEPI]: [2] deﬁnite
Appendix C. A method to ﬁll-in missing values
The method we describe in this appendix was used to
address the missing values problem in the PORT data-
base.7 The method is an iterated k-nearest neighbor
method. It is, essentially, a nonparametric EM-style
algorithm using Gibbs sampling.
Consider a data set comprising a set of cases, each
represented as a set of attributes with values. Most of
the values are known; some are initially missing. We will
refer to these initially-missing values as ‘‘unknown,’’
even after the program has ﬁlled in estimated values
for them. We use the term ‘‘missing’’ for values that
do not yet have an estimate.
C.1. The basic algorithm (one-nearest-neighbor version)
For each case C in the data set,
For each variable X in case C,
If the value of variable X is unknown, then
Produce a new estimate of the value of variable X of
case C using the Nearest Neighbor algorithm. (See
below for details.) The basic idea is to ﬁnd the other
case in the data set that most closely resembles case
C, considering only those cases that have a known
value for variable X. Call this ‘‘nearest neighbor’’ case
C 0. Variable X of case C 0 now becomes the new
estimate for the unknown variable X of case C.
Continue until the whole data set has been scanned
and a new estimate has been created for every un-
known variable in the data set.
Repeat this entire procedure until either there is no
further change or until a ﬁxed limit on the number
of iterations has been reached.
As the example below will show, often there is an
advantage to iterating this procedure more than once.
The estimated values ﬁlled in during the ﬁrst pass may
alter the nearest neighbor choices during the second
pass. This, in turn, may change some of the estimated
values. Normally, only a small number of iterations
are needed before the ﬁlled-in values converge.
C.2. Finding the nearest neighbor
Given a case C and an variable X whose value is un-
known, we want to ﬁnd the nearest neighbor to C. To do
this, we must compute the distance between C and every
other case in the data set that has a known value for var-
iable X. Then we simply pick the case whose distance is
smallest. We used simple unweighted Euclidean distance
to measure the distance between cases.
During the ﬁrst iteration of the algorithm, we will not
yet have computed an estimate for some of the unknown
values. Provision must be made for computing the diﬀer-
ence between the values of some variable X when that
value is unknown for one of the cases. In this case, we
compute the average of the X value for every case in
which X is known, and we use that average as the esti-
mated value for the unknown X.
It is also possible that the value of some variableXwill
bemissing for both of the cases being compared. (This can
occur if case C has two unknown variables.) In this case,
we compute the average diﬀerence between X values over
the entire data set, andweuse this diﬀerence as an estimate
of the distance between the two unknown X values.
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